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 ORIGINAL ARTICLE 
 Symptoms, signs, and tests: The general practitioner ’ s comprehensive 
approach towards a cancer diagnosis 
 BENEDICTE IVERSEN  SCHEEL  &  KNUT  HOLTEDAHL 
 Department of Community Medicine, UiT The Arctic University of Norway, Troms ø , Norway 
 Abstract 
 Objective . To study the relative importance of different tools a GP can use during the diagnostic process towards cancer 
detection.  Design . Retrospective cohort study with prospective registration of cancer in general practice.  Setting and subjects . 
One hundred and fi fty-seven Norwegian general practitioners (GPs) reported 261 cancer patients.  Method . During 
10 consecutive days, GPs registered all patient consultations and recorded any presence of seven focal symptoms and three 
general symptoms, commonly considered as warning signs of cancer (WSC). Follow-up was done six to 11 months later. 
For each patient with new or recurrent cancer, the GP completed a questionnaire with medical-record-based information 
concerning the diagnostic procedure.  Results . In 78% of cancer cases, symptoms, signs, or tests helped diagnose cancer. In 
90 cases, there were 131 consultation-recorded WSC that seemed related to the cancer. Further symptoms were reported 
for another 74 cases. Different clinical signs were noted in 41 patients, 16 of whom had no previous recording of symptoms. 
Supplementary tests added information in 59 cases; in 25 of these there were no recordings of symptoms or signs. Sensitiv-
ity of any cancer-relevant symptom or clinical fi nding ranged from 100% for patients with uterine body cancer to 57% for 
patients with renal cancer.  Conclusion . WSC had a major role as initiator of a cancer diagnostic procedure. Low-risk-but-
not-no-risk symptoms also played an important role, and in 7% of patients they were the only symptoms. Clinical fi ndings 
and/or supplementary procedures were sometimes decisive for rapid referral. 
 Key Words:  Early detection of cancer ,  early diagnosis ,  family practice ,  general practice ,  neoplasms ,  Norway ,  pathological conditions , 
 signs and symptoms 
distinguish reasonably well between cancer and not-
cancer [2]. Another article based on this material 
reported the frequency and predictive value of warn-
ing signs of cancer (WSC) at the time of the con-
sultation, and it was shown that 40% of the cancer 
patients had presented one or more WSC weeks or 
months before the diagnosis of cancer had been 
made [3]. Although several WSC have been studied 
in different settings [4], less is known about the 
association between pre-diagnostic cancer and lower 
risk symptoms, also called low-risk-but-not-no-risk-
symptoms, meaning symptoms not ordinarily listed 
as alarm symptoms of cancer [5]. The relative impor-
tance of pre-diagnostic cancer-related clinical fi nd-
ings is not well known, nor is the role of laboratory 
 Background 
 A general practitioner (GP) can contribute to the 
early diagnosis of cancer through thoughtful and 
rational clinical work and referral to more specialized 
services. For a GP, diagnostic thinking generally 
starts with symptoms a patient presents. Studies of 
symptoms and where they lead may produce useful 
evidence, but more comprehensive studies of how 
the GP works clinically may increase our under-
standing. A previous study in general practice showed 
potential for improvement of medical history-taking, 
performance of clinical examinations, and choice of 
supplementary tests and referrals [1]. 
 In a cohort of patients consulting in general 
practice, it has been shown that GPs manage to 
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tests and imaging. In this third cohort-based article 
we report our fi ndings from the follow-up question-
naire that was designed to collect information on all 
kinds of symptoms, clinical fi ndings, and supple-
mentary tests that might have triggered a GP ’ s sus-
picion of cancer after the initial consultation, but 
before diagnosis. 
 Material and methods 
 All Norwegian GPs (3910) received a questionnaire 
where they were asked to perform an initial symp-
tom registration during 10 working days for all con-
secutively consulting patients (Supplementary 
Appendix 1 available online at http://dx.doi.org/10.
3109/02813432.2015.1067512). Completed regis-
trations for 51 073 consulting patients were returned 
by 396 GPs (10%). Details regarding the initial 
registrations and exclusions have been described 
previously [3]. During follow-up 6 – 7 months later, 
283 GPs (71%) reported whether or not any of 
their original patients had developed cancer. Cases 
were reported by 157 GPs, who completed a separate 
questionnaire for each of 261 cancer patients ’ illness 
career (Supplementary Appendix 2 available online at 
http://dx.doi.org/10.3109/02813432.2015.1067512). 
New cases of cancer and new recurrences were to 
be reported, but not previously known cases with 
stable or progressive disease after initial cancer treat-
ment. The GP was asked to fi nd relevant patient 
information in the electronic medical record, with 
details of the patient ’ s present status and the locali-
sation and spread of the tumour. Free text space 
encouraged comments clarifying the role of symp-
toms and signs and their possible relationship with 
the cancer diagnosed. 
 Sex, date of birth, and date of the initial consul-
tation linked the two registrations. In this way we 
received medical record-based information both 
concerning the WSC previously recorded and 
regarding further symptoms occurring before diag-
nosis. Various clinical signs and test results were 
also reported. 
 The information from the follow-up question-
naire was combined with the initial WSC data, 
where seven focal and three general WSC were 
recorded (Table I, with abbreviations used in the 
article). The WSC studied here have been used in 
different combinations in several previous studies, 
and in information campaigns by cancer societies 
[1,4,6]. More recently, interest has increased con-
cerning lower risk symptoms [7], in this case 
defi ned as any non-WSC symptom described by 
the GPs. 
 In order to get the best possible picture of symp-
toms that could represent cues to the diagnosis of 
individual cancers, we decided to exclude consulta-
tion-recorded, focal WSC that by author consensus 
had no apparent relationship to the reported type of 
cancer. The criterion for exclusion of a WSC was 
that there was no apparent connection between that 
patient ’ s type of cancer and the symptom.  “ Other ” 
symptoms were excluded unless a further descrip-
tion made it probable that the symptom was pro-
duced by the cancer. In some cases, a focal WSC 
could be excluded because of a clear relationship 
with a specifi ed co-morbid condition. Some cases 
with apparently unrelated symptoms could be related 
to reported metastatic manifestations at the time of 
diagnosis. 
 A minimal number of similar cancers is neces-
sary to do a more detailed analysis of subgroups, i.e. 
located in one organ or group of organs where one 
might expect relatively similar symptoms within that 
group. Seven major types of cancer occurred in 
 Most cancers are symptomatic before diag- •
nosis, but the role of lower risk symptoms 
and of clinical fi ndings potentially available 
in general practice is unclear. 
 In 164 (62%) of 263 cancer cases, the GPs  •
reported symptoms that helped diagnose 
cancer. The percentage rose to 78% when 
clinical fi ndings and test results were 
added. 
 Lower risk symptoms were reported in 31  •
(12%) patients, and lower risk symptoms 
without any warning sign in 19 (7%) 
patients. 
 Among patients where clinical signs or tests  •
contributed to diagnosis, symptoms were 
absent in 39% and in 42%, respectively, 
showing the necessity of complementing 
reported symptoms with examinations and 
tests. 
 Table I. Warning signs of cancer. 
Symptoms studied Abbreviations
Focal symptoms: Non-healing skin lesion Skin lesion
Lump/nodule Lump
Unusual bleeding Bleeding











General symptoms: Unintentional weight loss Weight loss
Unusual fatigue Fatigue
Unusual pain Pain







































more than 20 patients, and three other types of can-
cer had at least seven patients. We decided to merge 
cancers with less than seven cases in a  “ miscella-
neous ” group, in order to get an idea about symp-
toms, signs, and tests contributing to the diagnosis 
of rarer cancers. 
 Statistics 
 All data were analysed in SPSS  ™  , version 19 (IBM 
Corp, Armonk, NY, USA). Chi-square was used to 
analyse differences between groups. Proportions 
were calculated with 95% confi dence interval (CI). 
The level of signifi cance was p    0.05. 
 Results 
 Of the 261 cancer patients, two had a double diag-
nosis, giving 263 cases. One hundred and six patients 
had an initial registration of one or more WSC [3]. 
Of 153 consultation-recorded WSC, 22 WSC were 
excluded. Ninety of the 106 patients had the remain-
ing 131 WSC (86%) that were considered related to 
the cancer. Of the 22 WSC considered not related to 
cancer, seven were apparently related to a specifi ed 
co-morbid condition. For the 15 others there was no 
logical link with cancer and further information was 
insuffi cient. The sex distribution among the different 
cancer patients in our study was not signifi cantly dif-
ferent from the sex distribution among Norwegian 
cancer patients [8]. Mean age ranged from 63 years 
in breast cancer patients to 76 years in patients with 
bladder cancer. 
 Fifty-seven cancer cases (22%) were recurrences. 
The proportion of recurrent cases varied consider-
ably and was highest for bladder cancer (47%), renal 
cancer (43%), and breast cancer (34%). There were 
no recurrences of lung cancer. 
 Metastases were demonstrated at the time of 
diagnosis in 31 patients with new cancer (15%) and 
21 with recurrent cancer (37%) (p    0.001). The 
proportion of metastatic cases was highest for ovar-
ian, pancreatic, and lung cancer. Symptoms from 
metastases may be expected to be less linked to the 
organ of the primary tumour, and this seemed to be 
the case for some patients. More dramatic clinical 
conditions, such as major infections and neurological 
symptoms leading to emergency hospitalization, 
often were due to a cancer that had metastasized. 
 Table II shows cancer-relevant symptoms and 
signs and test results reported by the GPs from the 
medical journal as well as from the consultation, 
for each type of cancer. In addition to the 90 cases 
with 131 consultation-recorded WSC, 74 cases had 
additional symptoms before diagnosis, giving a total 
of 164 (62%) cases with symptoms. In 22 of the 90 
cases with initial WSC, new symptoms added to the 
consultation-recorded WSC, giving 96 patients with 
additional symptoms. Of these 96 patients, 31 had 
lower risk symptoms. Altogether, the 96 patients had 
74 symptoms corresponding to WSC and 33 lower 
risk symptoms. Several non-WSC or lower risk symp-
toms were reported for most types of cancer. The 
most frequent of these were six cases with prostatism 
in prostatic cancer, and dyspnoea was reported in six 
patients with different cancers. Lower risk symptoms 
only without any simultaneous WSC were reported 
for 19 patients (7%) with different kinds of cancer. 
 Symptoms considered as typical WSC for some 
common cancers were not necessarily very frequent. 
 “ Digestive problem ” was noted in 25 cases and 
 “ bleeding ” in eight cases of the 68 cancers of the 
digestive organs. Of the 35 breast cancer patients, ten 
had a  “ lump ” . Of 23 lung cancer patients, eight had 
 “ cough ” . In 12 cases of malignant melanoma  “ mole ” 
was noted in seven cases,  “ lump ” , in two cases and 
 “ skin lesion ” in two cases. The last case lacked infor-
mation on how it was diagnosed. This kind of varying 
symptom perception was also found for the 12 cases 
of squamous cell carcinoma of skin, although  “ skin 
lesion ” had been noted in half of the cases. 
 Clinical fi ndings were noted in 41 patients (16%), 
16 (39%) of whom had no previous recording of 
symptoms, and these fi ndings varied considerably. 
Inspection and palpation including rectal palpation 
often gave clues to the diagnosis. Supplementary 
tests added information in 59 cases (22%); in 25 
(42%) of these there were no recordings of symp-
toms or signs. Among test-based signals noted by the 
GP, anaemia was clearly the most frequent and 
occurred in 15 patients. Of eight patients with anae-
mia and colorectal cancer, only one patient also had 
a recording of  “ bleeding ” . Of the six patients with 
anaemia and other cancers, two also had  “ bleeding ” . 
Compared with the 25 patients in total with a record-
ing of  “ bleeding ” either at the initially recorded con-
sultation or later on before diagnosis, anaemia was 
more than half as frequent as an independent signal 
of cancer. Occult blood in stool was noted in only 
three cases of colorectal cancer, in one case of 
stomach cancer, and in one generalized cancer (see 
Table II). 
 Table III refl ects how GPs can gain progressively 
more comprehensive diagnostic knowledge concern-
ing a patient ’ s ailment. In 78% (95% CI 73 – 83%) of 
the cancer cases, the GPs reported symptoms, signs, 
or tests that helped diagnose cancer (Table III). Sen-
sitivity of any cancer-relevant symptom or clinical 
fi nding ranged from 100% for patients with uterine 
body cancer to 57% for patients with renal cancer. 
Sensitivity of any cancer-related symptom was 62% 


















































































































































































































































































 *   *




































































































































































































































 *   *











































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































   N
    

















    













    













    






























r    









    




















   











































































  ‘ C
ou
gh













































































.   


































































































































































   
  *   *






















































.   
  *   *














































































































































































































































































































































































.   






































    
and almost twice as high as the sensitivity of WSC 
recorded when the patient consulted. Screening 
procedures like mammography, PSA, or cervical 
smear had been performed on several patients, and 
among these 11 (4%) of 263 cases were specifi ed by 
the GP as asymptomatic. In the 58 cases not appear-
ing in Table III, the diagnosis was either made during 
investigation for other disease, or there was a lack of 
information regarding symptoms and signs. How-
ever, in about half of these cases the GP had noted 
that the diagnostic process had been initiated on the 
basis of symptoms that were not specifi ed. 
 Discussion 
 Statement of principal fi ndings 
 The intention of this paper is to describe symptoms, 
signs, and tests that contributed to the diagnosis of 
cancer after the patients had consulted in general 
practice. Approximately one in three patients pre-
sented a WSC during the consultation and almost 
two in three experienced a cancer-relevant symp-
tom before diagnosis. These fi gures testify to the 
importance of well-known alarm symptoms and to 
the variety of lower risk symptoms that also may 
signal cancer. Seven per cent of patients experi-
enced lower risk symptoms only, while the diagnos-
tic contribution from lower risk symptoms seemed 
modest when there was also a WSC. The above fi g-
ures are minimum fi gures because some patients 
had unspecifi ed symptoms, and because there may 
have been symptoms not reported or described in 
the medical journal. If one includes clinical exami-
nation and results from simple tests that are acces-
sible for most GPs, symptoms and/or signs were 
present in almost four of fi ve patients. 
 Among the remaining cases, some were asymp-
tomatic and were detected through screening or case 
fi nding. At least seven of 10 positive mammograms 
were routine screening cases, contributing to the low 
symptom sensitivity fi gures for breast cancer. How-
ever, the rationale behind screening procedures is the 
possibility of diagnosing a cancer before symptoms 
appear, because local symptoms for some cancers are 
associated with systemic disease. High sensitivity of 
symptoms is valuable mainly when symptoms tend 
to appear early, like haematuria in bladder cancer or 
bleeding from a uterine body cancer. Most of the 
PSA tests were ordered on the basis of symptoms, 
but in some cases this was not clear. The main pic-
ture is that in most cases of cancer there will be 
manifestations of the disease that are potentially 
detectable by the GP. Clinical signs sometimes gave 
cues to increased suspicion and appropriate referral. 
These were important in the few cases of oral cancer. 
In renal cancer cases neither symptoms nor signs 
were prominent. 
 Among useful laboratory results, anaemia is yet 
again shown to merit an explanation when diagnosed. 
GPs should perform a haemoglobin measurement in 
unclear cases, whether or not  “ bleeding ” is present. 
Occult blood in stool (OBS) may have greater 
diagnostic utility than has been shown in our study, 
 Table III. Sensitivity of cancer relevant symptoms and signs in relation to different types of cancer. 261 patients with 263 





Symptoms and clinical 
fi ndings
Symptoms, signs and test 
results
Type of cancer N N Sensitivity 95% CI N Sensitivity 95% CI N Sensitivity 95% CI N Sensitivity 95% CI
Colorectal 46 18 39% 26 – 54% 30 65% 51 – 77% 33 72% 57 – 83% 37 80% 67 – 89%
Other digestive organs 22 10 45% 27 – 65% 15 68% 47 – 84% 16 73% 52 – 87% 17 77% 57 – 90%
Lung 23 10 43% 26 – 63% 17 74% 54 – 87% 20 87% 68 – 95% 21 91% 73 – 98%
Skin 24 9 38% 21 – 57% 21 88% 69 – 96% 21 88% 69 – 96% 21 88% 69 – 96%
Breast 35 9 26% 14 – 42% 15 43% 28 – 59% 17 49% 33 – 64% 26 74% 58 – 86%
Uterine body 7 3 43% 16 – 75% 7 100% 65 – 100% 7 100% 65 – 100% 7 100% 65 – 100%
Prostate 27 4 15% 6 – 32% 11 41% 25 – 59% 14 52% 34 – 69% 18 67% 48 – 81%
Renal 7 2 29% 8 – 64% 4 57% 25 – 84% 4 57% 25 – 84% 4 57% 25 – 84%
Bladder 15 7 47% 25 – 70% 11 73% 48 – 89% 11 73% 48 – 89% 13 87% 62 – 96%
Lymphoid/
hematopoietic
28 10 36% 21 – 54% 15 54% 36 – 70% 17 61% 42 – 76% 20 71% 53 – 85%
Miscellaneous 29 8 28% 15 – 46% 18 62% 44 – 77% 20 69% 51 – 83% 21 72% 54 – 85%
All types of cancer 263 90 34% 29 – 40% 164 62% 56 – 68% 180 68% 63 – 74% 205 78% 73 – 83%
 WSC   Warning signs of cancer. 
 Any pre-diagnostic symptom   WSC   additional (non-WSC) symptoms. Information from consultation registrations and from medical 
records combined. 
 N for Any pre-diagnostic symptom may be lower than the sum of cases with symptoms in Table II, because one patient may have both 
initial and (different) additional symptoms. 
 N for clinical fi ndings adds only cases where no symptoms were recorded, and N that includes test results adds cases where there was no 
recorded contributions from symptoms or clinical fi ndings. 






































and symptoms plus a positive test warrant further 
investigation [9]. 
 The probability of diagnosing a recurrent cancer 
was greater for some forms of cancer, i.e. urinary 
cancer and breast cancer. That there were no recur-
rences of lung cancer refl ects the serious nature of 
this type of cancer. It is encouraging that only one in 
10 new cancers had evidence of metastatic spread at 
the time of diagnosis. This means that competent 
cancer-diagnostic work by the GP may represent a 
prognostic difference for many patients. The task is 
even more challenging for recurrent cancer cases, 
where one in three patients had metastases when 
diagnosed. A previous cancer diagnosis is always a 
red fl ag for GPs. 
 Strengths and weaknesses of our study 
 The prospective nature of the follow-up ascertained 
that neither the patient nor the GP knew about the 
cancer diagnosis at the time of WSC registration 
[10]. However, symptoms presenting before diagno-
sis but after the initial consultation do not show in 
our cross-sectional consultation data. The combina-
tion with medical record-based symptom informa-
tion from the GP allowed for a more complete picture 
of the diversity of symptoms preceding a diagnosis 
of cancer. This picture is comparable with the spec-
trum of symptoms found in case-control interviews 
or questionnaire studies, but without important 
potential sources of bias like recall bias, which may 
be different for a personally affected patient and a 
more neutral control patient. Data in medical records 
are imperfect, but they offer a unique opportunity 
to review an entire clinical course [11]. Because 
the study dealt with cancer, it is possible that any 
under-reporting may have been more important for 
lower-risk symptoms than for WSC. 
 The distinction between additional symptoms 
and clinical signs, or between signs and supplemen-
tary tests, was not always clear, as in the cases of 
urinary retention and of leg oedema due to deep vein 
thrombosis, or in anaemia. The important point 
is that such symptoms, signs, or test results offer 
diagnostic possibilities for the GP. 
 The symptoms cover a period of up to 11 months 
preceding the diagnoses, although most recorded 
symptoms occurred during the last three to four 
months before diagnosis. With a few exceptions, 
most cancer-related symptoms seem to have been 
recorded, forming a relatively complete picture of 
the broad variation in symptoms for each type of 
cancer. Despite the modest number of cancer cases, 
it is probable that the spectrum of symptoms resem-
bles the spectrum for all cases of similar cancers in 
Norway. This is because all consulting patients were 
registered consecutively, and the cancer cases can 
be assumed to have been distributed randomly 
among the GPs. The low response rate among GPs 
was foreseen and not considered important because 
of this haphazard distribution of cancer cases in the 
surgeries. 
 The number of cancer cases of each type is small, 
with broad confi dence intervals for calculated sensi-
tivity fi gures. This limits the possibility of fi nding 
nuances in the pre-diagnostic role of symptoms, 
clinical procedures, etc. However, where differences 
between types of cancer could be expected, fi ndings 
mainly go in the expected direction, suggesting that 
the data are reliable. 
 Comparison with other studies 
 We think our study gives a rather comprehensive 
picture of the information available to the GP from 
consultation to diagnosis, and more so than most 
other studies. It is established that alarm symptoms 
are valid in relation to cancer and in many cases 
contribute to the diagnosis [6]. However, the absence 
of such symptoms does not mean absence of cancer 
[12]. Hamilton [5] emphasized the important role 
of lower risk symptoms, which are less apt to be 
referred to  “ fast track ” diagnosis. In primary care, 
variability of symptoms has been demonstrated for 
colorectal cancer [13 – 16], bladder cancer [17], uter-
ine cancer [18], and pancreatic cancer [19]. For 
urological cancer it has been found that the presence 
of other symptoms in addition to haematuria did not 
infl uence predictive value [20]. Anaemia has been 
studied, especially in relation to colorectal cancer 
[21]. The conclusions in these studies are not very 
different from ours. Prostatism is a problematic 
symptom because it signals both benign and malig-
nant growth, and prostatic cancer cells are very com-
mon in elderly men. When a PSA test is considered, 
patients should be informed about the nature and 
possible consequences of PSA test results [22,23]. 
 Implications for clinical practice and further research 
 Our study improves our understanding of the clinical 
road towards a cancer diagnosis in general practice. 
It adds to the understanding of how a GP can deal 
with the rather unspecifi c symptoms that patients 
present daily, where cancer is one possibility among 
many others. WSC must be explained, and even 
lower-risk symptoms cannot be overlooked. Our fi nd-
ings show how the patient collection of further infor-
mation through appropriate clinical examination and 
supplementary testing can provide a more rational 
basis for referral. It is important to seek combinations 
of symptoms and signs and perhaps even  “ gut feeling ” 






































    
[24,25], where the combination maximizes sensitivity 
[26] as well as specifi city, in order to increase the 
positive predictive value. Commonly, it is the com-
bined diagnostic approach that allows the distinction 
of probable cancer from non-cancer [2]. Some of the 
clinical fi ndings reported in our patients may have 
been decisive for a rapid referral to specialist diagnos-
tics. Cancers with few symptoms and signs like renal 
cancer, or with symptoms and signs usually associ-
ated with advanced disease, like pancreatic or ovarian 
cancer, should be consciously considered by the GP 
when there are vague but persistent symptoms. Some 
types of cancer had more distinct symptoms than oth-
ers, but rare cancers seem to have about the same 
symptom frequency as more frequent cancers. 
 The cognitive mechanisms that make a GP sus-
pect cancer in a patient are complex [27,28] and 
deserve attention in medical schools. Errors are 
unavoidable but may be minimized [29], and the 
GPs ’ closeness to patients is important. The combi-
nation of high-frequency symptoms and low-fre-
quency cancers is a challenge to the diagnostic skills 
of GPs. The diagnostic role of non-WSC symptoms 
and of clinical fi ndings merits further research. 
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